Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy is a research paper published in Trends in Immunology (2022). On theSindex it has a DataRank of 0. It has been cited 219 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
National Institutes of Health
Grant: CA163205
National Institutes of Health
Grant: CA265095
National Institutes of Health
Grant: NS106170
National Institutes of Health
Grant: CA223400
National Institutes of Health
Grant: CA210087
National Institutes of Health
Grant: AI129582
National Institutes of Health
Grant: CA264512
National Institutes of Health
Grant: CA247550
National Institutes of Health
Grant: CA266457
Leukemia & Lymphoma Society
Grant: 1364-19
NCI NIH HHS
Grant: R01 CA266457
NINDS NIH HHS
Grant: R01 NS106170
NCI NIH HHS
Grant: R01 CA068458
NCI NIH HHS
Grant: R35 CA210087
NCI NIH HHS
Grant: R01 CA265095
NCI NIH HHS
Grant: R21 CA223400
NCI NIH HHS
Grant: P01 CA163205
NIAID NIH HHS
Grant: R01 AI129582
NCI NIH HHS
Grant: R01 CA247550
NCI NIH HHS
Grant: U19 CA264512
Breast Cancer Alliance
FWCI
13.49
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals